Literature DB >> 32725172

The Current Status of Psychedelics in Psychiatry.

David Nutt1, Robin Carhart-Harris1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32725172     DOI: 10.1001/jamapsychiatry.2020.2171

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  26 in total

1.  Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.

Authors:  Conor H Murray; Ilaria Tare; Claire M Perry; Michael Malina; Royce Lee; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2021-10-06       Impact factor: 4.530

Review 2.  Psychedelics in the treatment of unipolar and bipolar depression.

Authors:  Oliver G Bosch; Simon Halm; Erich Seifritz
Journal:  Int J Bipolar Disord       Date:  2022-07-05

3.  Classic Psychedelics and Human-Animal Relations.

Authors:  Elin Pöllänen; Walter Osika; Cecilia U D Stenfors; Otto Simonsson
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

4.  Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.

Authors:  William E Rosa; Zachary Sager; Megan Miller; Ilan Bernstein; Alden Doerner Rinaldi; Katie Addicott; Michael Ljuslin; Chris Adrian; Anthony L Back; Jamie Beachy; Anthony P Bossis; William S Breitbart; Mary P Cosimano; Stacy M Fischer; Jeffrey Guss; Emma Knighton; Janis Phelps; Brian D Richards; William A Richards; James A Tulsky; Monnica T Williams; Yvan Beaussant
Journal:  J Palliat Med       Date:  2022-03-14       Impact factor: 2.947

5.  Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.

Authors:  Otto Simonsson; Simon B Goldberg
Journal:  J Psychoactive Drugs       Date:  2022-01-09

6.  Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.

Authors:  Yvan Beaussant; James Tulsky; Benjamin Guérin; Claudia Schwarz-Plaschg; Justin J Sanders
Journal:  J Palliat Med       Date:  2021-04-13       Impact factor: 2.947

7.  Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

Authors:  Roberta Murphy; Hannes Kettner; Rick Zeifman; Bruna Giribaldi; Laura Kartner; Jonny Martell; Tim Read; Ashleigh Murphy-Beiner; Michelle Baker-Jones; David Nutt; David Erritzoe; Rosalind Watts; Robin Carhart-Harris
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

8.  Associations between lifetime classic psychedelic use and markers of physical health.

Authors:  Otto Simonsson; James D Sexton; Peter S Hendricks
Journal:  J Psychopharmacol       Date:  2021-03-09       Impact factor: 4.153

Review 9.  Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.

Authors:  John R Kelly; Claire M Gillan; Jack Prenderville; Clare Kelly; Andrew Harkin; Gerard Clarke; Veronica O'Keane
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

10.  Analysis of recreational psychedelic substance use experiences classified by substance.

Authors:  Adrian Hase; Max Erdmann; Verena Limbach; Gregor Hasler
Journal:  Psychopharmacology (Berl)       Date:  2022-01-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.